| Secondary |
| Drug Use For Unknown Indication |
16.4% |
| Product Used For Unknown Indication |
14.9% |
| Renal Transplant |
10.2% |
| Immunosuppression |
9.7% |
| Juvenile Arthritis |
5.7% |
| Bone Marrow Conditioning Regimen |
4.0% |
| Prophylaxis |
3.8% |
| Psoriatic Arthropathy |
3.8% |
| Mycosis Fungoides |
3.3% |
| Psoriasis |
3.3% |
| Rheumatoid Arthritis |
3.2% |
| Liver Transplant |
3.0% |
| Endometrial Cancer |
2.8% |
| Prophylaxis Against Transplant Rejection |
2.8% |
| Acute Graft Versus Host Disease |
2.5% |
| Lung Transplant |
2.5% |
| Graft Versus Host Disease |
2.3% |
| Epstein-barr Virus Associated Lymphoproliferative Disorder |
2.0% |
| Colitis Ulcerative |
1.8% |
| Diabetes Mellitus |
1.8% |
|
| Transplant Rejection |
9.5% |
| Off Label Use |
7.1% |
| Aplasia Pure Red Cell |
6.0% |
| Nausea |
6.0% |
| Pneumonia |
6.0% |
| Pyrexia |
6.0% |
| Sepsis |
6.0% |
| Gastroenteritis |
4.8% |
| Osteonecrosis |
4.8% |
| Premature Baby |
4.8% |
| Sensation Of Pressure |
4.8% |
| Thrombocytopenia |
4.8% |
| Weight Increased |
4.8% |
| Cardio-respiratory Arrest |
3.6% |
| Death |
3.6% |
| Drug Ineffective |
3.6% |
| Pseudomonal Sepsis |
3.6% |
| Renal Failure |
3.6% |
| Respiratory Arrest |
3.6% |
| Sclerosing Encapsulating Peritonitis |
3.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.7% |
| Idiopathic Thrombocytopenic Purpura |
14.9% |
| Drug Use For Unknown Indication |
11.0% |
| Rheumatoid Arthritis |
9.9% |
| Prophylaxis |
5.2% |
| Prophylaxis Against Transplant Rejection |
3.5% |
| Non-small Cell Lung Cancer |
3.2% |
| Premedication |
3.2% |
| Bone Marrow Conditioning Regimen |
3.0% |
| Acute Graft Versus Host Disease |
2.9% |
| Immunosuppressant Drug Therapy |
2.5% |
| Hypertension |
2.5% |
| Infection Prophylaxis |
2.4% |
| Renal Transplant |
2.4% |
| Osteoporosis |
2.2% |
| Vitamin Supplementation |
2.2% |
| Crohn's Disease |
2.2% |
| Prophylaxis Against Graft Versus Host Disease |
2.0% |
| Colitis Ulcerative |
1.6% |
| Colorectal Cancer |
1.5% |
|
| Drug Ineffective |
12.8% |
| Thrombocytopenia |
10.4% |
| Pyrexia |
8.4% |
| Death |
8.0% |
| Therapeutic Response Decreased |
7.3% |
| White Blood Cell Count Increased |
6.2% |
| Pulmonary Embolism |
5.8% |
| Vomiting |
4.9% |
| Pneumonia |
4.6% |
| Respiratory Failure |
3.8% |
| Sepsis |
3.3% |
| Oedema Peripheral |
3.1% |
| Septic Shock |
3.1% |
| Weight Decreased |
2.9% |
| Weight Increased |
2.9% |
| Osteonecrosis |
2.7% |
| Thrombocytosis |
2.7% |
| Renal Failure |
2.4% |
| Tremor |
2.4% |
| Tuberculosis |
2.4% |
|
| Interacting |
| Product Used For Unknown Indication |
22.2% |
| Sinusitis |
22.2% |
| Back Pain |
11.1% |
| Blood Cholesterol Increased |
11.1% |
| Respiratory Tract Infection |
11.1% |
| Rheumatoid Arthritis |
11.1% |
| Smoking Cessation Therapy |
11.1% |
|
| Drug Interaction |
33.3% |
| Respiratory Tract Infection |
33.3% |
| Sinusitis |
33.3% |
|
